MSD has opened a $1bn facility in Durham located in the US state of North Carolina, to increase vaccine manufacturing ...

Apollo Cradle and Children’s Hospital in partnership with MSD Pharmaceuticals launched ‘Together for Her Well-being,’ an initiative aimed at empowering women with knowledge about self-care ...

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to ...

February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number ...

These young leaders are leveraging the insights and networks gained from the programme to create positive change in their communities and beyond.

NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bionoid Pharma, Inc. ("Bionoid") is pleased to announce the successful completion of its financial audits for the fiscal years 2022 and 2023 by ...

AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.

Vaccinex went public in 2018, raising around $40m to advance its pipeline of neurodegenerative disease therapies. The initial ...

Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...

The company also introduced Zyrix, its next-generation AI platform, which aims to speed up product development in enterprise ...

Endo, Inc. ("Endo" or the "Company") today announced it has entered into a definitive agreement to divest its International Pharmaceuticals business, primarily operated through Canada-based specialty ...

Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.